Physician profile
Tracy Becherer
NPI 1275268880
$3,793.55
in general payments reported to CMS, 2019-2025
13 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $354 · 2023: $795 · 2024: $1,344 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,439.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,834.67 | 2022-2025 | Infuse, Biotrue, Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $733.33 | 2022-2025 | Acuvue |
| Coopervision INC. | $506.32 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens, Paragon Crt |
| Biotissue Holdings INC. | $142.83 | 2025 | |
| Alcon Vision LLC | $133.62 | 2024-2025 | Total30, Precision7 |
| Horizon Therapeutics Plc | $117.70 | 2022 | |
| Abb Con-Cise Optical Group LLC | $94.16 | 2023 | Spectacle Lenses, Contact Lens |
| Tarsus Pharmaceuticals, INC. | $90.88 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $44.38 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $29.46 | 2022 | |
| Quidel Corporation | $25.71 | 2023 | |
| Sight Sciences, INC. | $23.64 | 2024 | Tearcare System |
| Novartis Pharmaceuticals Corporation | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Becherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.